메뉴 건너뛰기




Volumn 27, Issue SUPPL. 2, 2009, Pages

The question of heart failure in ONTARGET and TRANSCEND: Implications for clinical practice

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Heart failure; Renin?angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; RAMIPRIL; TELMISARTAN; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT;

EID: 69449108174     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000354518.90321.bb     Document Type: Review
Times cited : (1)

References (9)
  • 1
    • 0242654867 scopus 로고    scopus 로고
    • Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomized trials
    • Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362:1527-1535.
    • (2003) Lancet , vol.362 , pp. 1527-1535
    • Turnbull, F.1
  • 2
    • 52149090673 scopus 로고    scopus 로고
    • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis
    • Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens 2008; 26:1282-1289.
    • (2008) J Hypertens , vol.26 , pp. 1282-1289
    • Reboldi, G.1    Angeli, F.2    Cavallini, C.3    Gentile, G.4    Mancia, G.5    Verdecchia, P.6
  • 3
    • 0038203004 scopus 로고    scopus 로고
    • Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March
    • Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 2003; 21:1055-1076.
    • (2003) J Hypertens , vol.2003 , Issue.21 , pp. 1055-1076
    • Staessen, J.A.1    Wang, J.G.2    Thijs, L.3
  • 4
    • 34147116836 scopus 로고    scopus 로고
    • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system
    • Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25:951-958.
    • (2007) J Hypertens , vol.25 , pp. 951-958
    • Turnbull, F.1    Neal, B.2    Pfeffer, M.3    Kostis, J.4    Algert, C.5    Woodward, M.6
  • 6
    • 64949190067 scopus 로고    scopus 로고
    • Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: A meta-analysis
    • Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J 2009; 30:679-688.
    • (2009) Eur Heart J , vol.30 , pp. 679-688
    • Verdecchia, P.1    Angeli, F.2    Cavallini, C.3    Gattobigio, R.4    Gentile, G.5    Staessen, J.A.6    Reboldi, G.7
  • 7
    • 0029960897 scopus 로고    scopus 로고
    • Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
    • Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27:1214-1218.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1214-1218
    • Moser, M.1    Hebert, P.R.2
  • 9
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor of calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor of calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
    • (2002) JAMA , vol.288 , pp. 2981-2997


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.